Search - tctmd.com

Displaying 1 - 20 of 41

Sort: Relevancy | Date

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

News Conference News TCT 2021

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

November 06, 2021

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

News Conference News TCT 2021

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

November 05, 2021

Captis: Full-Body Embolic Protection Device

Presentation TCT 2021

Captis: Full-Body Embolic Protection Device

Presenter: Haim Danenberg

November 04, 2021

Cerebral Protection in TAVR: The PROTEMBO C Trial

Presentation TCT 2021

Cerebral Protection in TAVR: The PROTEMBO C Trial

Presenter: Tobias Schmidt

November 04, 2021

LAA Closure with the Laminar Device: technology and Clinical Update

Presentation TCT 2021

LAA Closure with the Laminar Device: technology and Clinical Update

Presenter: Jason H. Rogers

November 04, 2021

World’s First Dedicated 3D Sizing LAA Exclusion Device (Paladin Medical’s Trinity System)

Presentation TCT 2021

Introducing XCLUDE Integrated Solution. World's First Dedicated LAA 3D Sizing Device and Next-Gen LAA Exclusion Device

Presenter: Flavio Airoldi

November 04, 2021

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Presentation TCT 2021

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Presenter: Zachi Berger

November 04, 2021

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

Presentation TCT 2021

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

Presenter: Jens Erik Nielsen-Kudsk

November 04, 2021

TCT 703: Concomitant Transcatheter Mitral-Valve-in-Valve (MViV) with Left Atrial Appendage (LAA) Occlusion Device in a High-Risk Patient Unable to Tolerate Anticoagulation

Presentation TCT 2021

TCT 703: Concomitant Transcatheter Mitral-Valve-in-Valve (MViV) with Left Atrial Appendage (LAA) Occlusion Device in a High-Risk Patient Unable to Tolerate Anticoagulation

Presenter: Peter Sayegh

November 04, 2021

TCT 692: Percutaneous Left atrial appendage occlusion after failed surgical closure with Left Atrial Appendage Epicardial Clip

Presentation TCT 2021

TCT 692: Percutaneous Left atrial appendage occlusion after failed surgical closure with Left Atrial Appendage Epicardial Clip

Presenter: Kofi Ansah

November 04, 2021

Half-Dose DOAC May Be a Good Post-Watchman Option

News Daily News

Half-Dose DOAC May Be a Good Post-Watchman Option

October 14, 2021

LAA Closure Feasible in Patients With Thrombus: Registry

News Conference News TCT 2021

LAA Closure Feasible in Patients With Thrombus: Registry

Michael O'Riordan

October 13, 2021

FDA Investigating Possible Sex Differences in LAAO Outcomes

News Daily News

FDA Investigating Possible Sex Differences in LAAO Outcomes

September 27, 2021

Delayed Peridevice Leak Not Uncommon After Watchman Implant

News Daily News

Delayed Peridevice Leak Not Uncommon After Watchman Implant

September 03, 2021

Amulet IDE: LAA Occluder Performs Well Against Watchman

News Conference News ESC 2021

Amulet IDE: LAA Occluder Performs Well Against Watchman

August 30, 2021

FDA Approves Amplatzer Amulet LAA Occluder

News Daily News

FDA Approves Amplatzer Amulet LAA Occluder

August 17, 2021

Short-term LAA Occlusion Outcomes Worse in Women

News Daily News

Short-term LAA Occlusion Outcomes Worse in Women

August 17, 2021

RF-Based Energy Closes Residual Leaks After Watchman Implantation

News Conference News HRS 2021

RF-Based Energy Closes Residual Leaks After Watchman Implantation

Michael O'Riordan

August 09, 2021

TCTMD’s Top 10 Most Popular Stories for July 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2021

August 02, 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

News Conference News TVT 2021

New-Generation Watchman FLX Maintains Good Results Through 2 Years

July 28, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.